Combined culture and metagenomic analyses reveal significant shifts in the composition of the cutaneous microbiome in psoriasis

Ewan A. Langan(University of Manchester), Johannes K.‐M. Knobloch(University Hospital Schleswig-Holstein), Saleh Ibrahim(Khalifa University of Science and Technology), Werner Solbach(University of Lübeck), Axel Künstner(University of Lübeck), Diamant Thaçi(University of Lübeck), Detlef Zillikens(University of Lübeck), John F. Baines(Christian-Albrechts-Universität zu Kiel), Mor Miodovnik(Tel Aviv University)
British Journal of Dermatology
April 15, 2019
10.1111/bjd.17989
Cited by 90

Related Papers

Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
|New England Journal of Medicine|2014|1.4k
Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus
|Journal of the American Academy of Dermatology|2008|597
Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial
|The Lancet|2015|569
Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials
|The Lancet|2021|538
Lymphocyte Circadian Clocks Control Lymph Node Trafficking and Adaptive Immune Responses
|Immunity|2017|461